Buy & Sell Citius Pharmaceuticals Inc (CTXR) – Citius Pharmaceuticals Inc Price Today
Key Stats
- $19.23MMarket Cap
- HealthSector
- -38.01%3M Drawdown
- $13.34MEnterprise Value
- -Dividend Yield
- 53% Buy | 47% SellTrading Activity
- 5 daysTypical Hold Time
Citius Pharmaceuticals Inc (CTXR) is currently valued at a market capitalization of $19.23M, with an enterprise value of $13.34M. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.54 and a high of $2.21, highlighting its annual price range. Over the past three months, Citius Pharmaceuticals Inc has recorded a drawdown of -38.01%, reflecting recent price volatility. On average, investors hold Citius Pharmaceuticals Inc for approximately 5 days, indicating typical investor behavior on the platform.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
Oil prices drop after Trump delays planned strike on Iran, easing supply disruption fears.
Oil prices fell sharply after U.S. President Donald Trump postponed a planned military strike on Iran following requests from Gulf leaders, reducing fears of immediate conflict that could disrupt global oil supplies. Brent crude futures dropped over ...

ELEKTROS Inc. gains momentum with lithium mining and EV charging tech, attracting global penny stock investors.
ELEKTROS Inc. celebrates its second consecutive day of positive trading momentum as new investors worldwide discover its lithium mining projects in Sierra Leone and patented electric vehicle charging technology. The company is positioned in key growt...

FIBRA Prologis retains BBB+ credit rating with stable outlook from S&P after Mexico's sovereign outlook improves.
FIBRA Prologis, a leading industrial real estate owner in Mexico, maintained its BBB+ credit rating with a stable outlook from S&P Global Ratings. This follows the upgrade of Mexico's sovereign outlook from Negative to Stable. S&P highlighted FIBRA P...
